Combination of AQP1 and β-catenin expression is an independent prognosis factor in astrocytoma patients.

Combination of AQP1 and β-catenin expression is an independent prognosis factor in astrocytoma patients.
复制标题

AQP1 和β-连环蛋白表达的组合是星形细胞瘤患者的独立预后因素。

DOI:
10.18632/oncotarget.19562
复制
发表时间:
2017-11-21
期刊:
影响因子:
--
通讯作者:
Ma Y
Ma Y
中科院分区:
其他
文献类型:
--
作者:
Zhang H;Qin F;Yang L;He J;Liu X;Shao Y;Guo Z;Zhang M;Li W;Fu L;Gu F;Ma Y

文献摘要

参考文献

被引文献

相似文献

以往的研究通常集中在肿瘤发生发展中的单个蛋白或基因上,实际上肿瘤的高度异质性和不同的信号通路在很大程度上促进了肿瘤的进展和肿瘤患者的结局。因此,使用组合生物标志物来评估预后特征和指导治疗逐渐被接受和迫切需要。β-catenin是星形细胞瘤进展中的一个众所周知的关键因子,并且其参与水通道蛋白1(aquaporin 1,AQP 1)介导的细胞迁移。本研究揭示了AQP 1在星形细胞瘤进展中的作用,并首次提供了AQP 1表达与β-catenin正相关的临床证据。进一步证实了AQP 1/β-catenin通路在星形细胞瘤进展中的作用。更重要的是,我们发现AQP 1和β-catenin的联合表达是星形细胞瘤患者的独立预后因素,并且它比单独的AQP 1或β-catenin更好地预测生存。总之,我们的研究为基于AQP 1和β-catenin表达的组合分析预测星形细胞瘤预后提供了一种新的更精确的方法。
Previous research usually focused on single protein or gene in tumor development, actually highly heterogeneous nature and different signaling pathways largely contribute to tumor progression and tumor patients' outcomes. Therefore, using combinatorial biomarkers to evaluate the prognostic features and guide management is gradually accepted and urgently needed. β-catenin is a well-known crucial factor in astrocytoma progression and it is involved in aquaporin1 (AQP1) mediated cell migration. In this study, we revealed the function of AQP1 in astrocytoma progression and provided the first clinical evidence that AQP1 expression was positively correlated with β-catenin. Furthermore, we proved the functional role of AQP1/β-catenin pathway in astrocytoma progression. More importantly, we discovered that combination of AQP1 and β-catenin expression was an independent prognosis factor for astrocytoma patients and it was a better survival predictor than either AQP1 or β-catenin alone. In conclusion, our study provided a novel more precise prognostication for predicting astrocytoma prognosis based on combinatorial analysis of AQP1 and β-catenin expression.
国际神经病理学协会 - 哈勒姆神经系统肿瘤分类和分级共识指南。
DOI: 10.1111/bpa.12171
发表时间: 2014-09
期刊: Brain pathology (Zurich, Switzerland)
影响因子: --
作者:
Louis DN;Perry A;Burger P;Ellison DW;Reifenberger G;von Deimling A;Aldape K;Brat D;Collins VP;Eberhart C;Figarella-Branger D;Fuller GN;Giangaspero F;Giannini C;Hawkins C;Kleihues P;Korshunov A;Kros JM;Beatriz Lopes M;Ng HK;Ohgaki H;Paulus W;Pietsch T;Rosenblum M;Rushing E;Soylemezoglu F;Wiestler O;Wesseling P;International Society Of Neuropathology--Haarlem
通讯作者: International Society Of Neuropathology--Haarlem
细胞质中水通道蛋白aquaporin1的表达与乳腺癌患者的预后呈负相关。
DOI: 10.18632/oncotarget.6994
发表时间: 2016-02-16
期刊: Oncotarget
影响因子: --
作者:
Qin F;Zhang H;Shao Y;Liu X;Yang L;Huang Y;Fu L;Gu F;Ma Y
通讯作者: Ma Y
DOI: 10.1016/j.bbadis.2014.07.030
发表时间: 2014-11-01
影响因子: 6.2
作者:
Madonna, Rosalinda;Geng, Yong-Jian;De Caterina, Raffaele
通讯作者: De Caterina, Raffaele
DOI: 10.1016/j.canlet.2012.05.024
发表时间: 2012-12-01
期刊: CANCER LETTERS
影响因子: 9.7
作者:
Kahlert, Ulf D.;Maciaczyk, Donata;Maciaczyk, Jaroslaw
通讯作者: Maciaczyk, Jaroslaw
DOI: 10.1007/s12032-010-9476-5
发表时间: 2011-06-01
期刊: MEDICAL ONCOLOGY
影响因子: 3.4
作者:
Liu, Xiangrong;Wang, Lei;Ling, Feng
通讯作者: Ling, Feng